Effects of Empagliflozin on Cardiac Structure in Patients With Type 2 Diabetes
Clinical trial NCT02998970 · UNKNOWN
Trial details
- NCT number
- NCT02998970
- Sponsor
- Unity Health Toronto
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2018-09-01
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.